Trial Profile
Clinical Trials Insight: 700031667
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 18 Mar 2008
Price :
$35
*
At a glance
- Drugs Oblimersen (Primary) ; Cyclophosphamide; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Registrational; Therapeutic Use
- Sponsors Genta (CEASED)
- 18 Mar 2008 New trial record.